Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Vatnak Vat-ho currently holds 87,000 shares of Akari Therapeutics Plc (AKTX), valued at approximately $0. This represents their equity stake as Chief Business Officer.
Based on SEC Form 4 filings, Vatnak Vat-ho has been a net neutral trader of AKTX stock. They have purchased $0 and sold $0 worth of shares.
Vatnak Vat-ho's most recent insider trade was on Oct 12, 2026, when they sold 87,000 shares at $0.00 per share.
Vatnak Vat-ho serves as Chief Business Officer at Akari Therapeutics Plc (AKTX). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Vatnak Vat-ho holds the position of Chief Business Officer at Akari Therapeutics Plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Vatnak Vat-ho has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Vatnak Vat-ho was on Oct 12, 2026, when they purchased $0 worth of AKTX shares. This transaction involved 87,000 shares at N/A per share.
Vatnak Vat-ho currently owns 87,000 shares of Akari Therapeutics Plc (AKTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Vatnak Vat-ho's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Vatnak Vat-ho has 1 Form 4 filings on record as an insider at Akari Therapeutics Plc.
Set alerts for Vatnak Vat-ho and 40,000+ other insiders.